Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement
Nov. 21, 2022, Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona® OsseoTi® Keel Tibia for cementless knee...
Recent Comments